

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 5.70554557 |
| 2 | polyketide metabolic process (GO:0030638) | 5.70554557 |
| 3 | doxorubicin metabolic process (GO:0044598) | 5.70554557 |
| 4 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.66462549 |
| 5 | response to pheromone (GO:0019236) | 4.10961345 |
| 6 | piRNA metabolic process (GO:0034587) | 3.97286376 |
| 7 | sperm motility (GO:0030317) | 3.88750941 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.73885444 |
| 9 | acrosome assembly (GO:0001675) | 3.66448281 |
| 10 | presynaptic membrane assembly (GO:0097105) | 3.57575464 |
| 11 | acrosome reaction (GO:0007340) | 3.56632401 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.46367066 |
| 13 | male meiosis (GO:0007140) | 3.44323771 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.43762284 |
| 15 | positive regulation of glycolytic process (GO:0045821) | 3.43643367 |
| 16 | motile cilium assembly (GO:0044458) | 3.42592559 |
| 17 | regulation of glucokinase activity (GO:0033131) | 3.39511202 |
| 18 | regulation of hexokinase activity (GO:1903299) | 3.39511202 |
| 19 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.38237456 |
| 20 | Golgi to endosome transport (GO:0006895) | 3.37506995 |
| 21 | DNA methylation involved in gamete generation (GO:0043046) | 3.33861923 |
| 22 | urinary tract smooth muscle contraction (GO:0014848) | 3.30964956 |
| 23 | macroautophagy (GO:0016236) | 3.29120196 |
| 24 | auditory receptor cell stereocilium organization (GO:0060088) | 3.28671315 |
| 25 | epithelial cilium movement (GO:0003351) | 3.27926619 |
| 26 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.25447083 |
| 27 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.22980840 |
| 28 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.22828878 |
| 29 | presynaptic membrane organization (GO:0097090) | 3.21430889 |
| 30 | startle response (GO:0001964) | 3.20845369 |
| 31 | inositol phosphate catabolic process (GO:0071545) | 3.20169294 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 3.14068947 |
| 33 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.12933840 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.07141175 |
| 35 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.06751482 |
| 36 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05287210 |
| 37 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.02188988 |
| 38 | inner ear receptor stereocilium organization (GO:0060122) | 3.01841956 |
| 39 | establishment of nucleus localization (GO:0040023) | 2.97718115 |
| 40 | calcium ion-dependent exocytosis (GO:0017156) | 2.97206252 |
| 41 | protein targeting to Golgi (GO:0000042) | 2.94341269 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 2.94128148 |
| 43 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.93501959 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 2.92987875 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 2.91128333 |
| 46 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.89466736 |
| 47 | insulin secretion (GO:0030073) | 2.89053684 |
| 48 | early endosome to late endosome transport (GO:0045022) | 2.88604455 |
| 49 | regulation of energy homeostasis (GO:2000505) | 2.87325748 |
| 50 | establishment of protein localization to Golgi (GO:0072600) | 2.86001227 |
| 51 | plasma membrane fusion (GO:0045026) | 2.84143497 |
| 52 | vocalization behavior (GO:0071625) | 2.83554154 |
| 53 | brain morphogenesis (GO:0048854) | 2.83343612 |
| 54 | positive regulation of protein autophosphorylation (GO:0031954) | 2.83177169 |
| 55 | multicellular organism reproduction (GO:0032504) | 2.82702317 |
| 56 | ketone body metabolic process (GO:1902224) | 2.81719097 |
| 57 | detection of calcium ion (GO:0005513) | 2.80670101 |
| 58 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.80139416 |
| 59 | cilium movement (GO:0003341) | 2.77848108 |
| 60 | protein localization to synapse (GO:0035418) | 2.77648163 |
| 61 | neuron remodeling (GO:0016322) | 2.76039303 |
| 62 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.76017471 |
| 63 | protein localization to cilium (GO:0061512) | 2.75945564 |
| 64 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75138970 |
| 65 | ER overload response (GO:0006983) | 2.74646097 |
| 66 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.74224248 |
| 67 | calcium ion import (GO:0070509) | 2.73871371 |
| 68 | axonemal dynein complex assembly (GO:0070286) | 2.71357823 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 2.71039690 |
| 70 | nitric oxide mediated signal transduction (GO:0007263) | 2.70239070 |
| 71 | nucleus localization (GO:0051647) | 2.70149886 |
| 72 | protein localization to Golgi apparatus (GO:0034067) | 2.69017777 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.68147137 |
| 74 | inositol phosphate dephosphorylation (GO:0046855) | 2.68147137 |
| 75 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.68138334 |
| 76 | keratinocyte development (GO:0003334) | 2.67740217 |
| 77 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.67125840 |
| 78 | intraciliary transport (GO:0042073) | 2.66732295 |
| 79 | neuron-neuron synaptic transmission (GO:0007270) | 2.63173955 |
| 80 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.62606186 |
| 81 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.61892142 |
| 82 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.61363033 |
| 83 | long-term synaptic potentiation (GO:0060291) | 2.59770704 |
| 84 | COPII vesicle coating (GO:0048208) | 2.57466626 |
| 85 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.56563040 |
| 86 | regulation of synaptic vesicle transport (GO:1902803) | 2.55512804 |
| 87 | polyol catabolic process (GO:0046174) | 2.55223175 |
| 88 | spermatid development (GO:0007286) | 2.54989515 |
| 89 | postsynaptic membrane organization (GO:0001941) | 2.54362398 |
| 90 | regulation of cilium movement (GO:0003352) | 2.53806855 |
| 91 | nerve growth factor signaling pathway (GO:0038180) | 2.53342130 |
| 92 | protein prenylation (GO:0018342) | 2.53116218 |
| 93 | prenylation (GO:0097354) | 2.53116218 |
| 94 | glycosphingolipid biosynthetic process (GO:0006688) | 2.52847255 |
| 95 | positive regulation of meiotic cell cycle (GO:0051446) | 2.52209957 |
| 96 | positive regulation of muscle hypertrophy (GO:0014742) | 2.52207697 |
| 97 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.52207697 |
| 98 | adaptation of signaling pathway (GO:0023058) | 2.51521613 |
| 99 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.51448482 |
| 100 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.50938944 |
| 101 | proline transport (GO:0015824) | 2.50509120 |
| 102 | cyclic nucleotide catabolic process (GO:0009214) | 2.50043621 |
| 103 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.48175322 |
| 104 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.47247676 |
| 105 | endocrine pancreas development (GO:0031018) | 2.46418719 |
| 106 | cell wall macromolecule catabolic process (GO:0016998) | 2.46326394 |
| 107 | cell wall macromolecule metabolic process (GO:0044036) | 2.46326394 |
| 108 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.46297281 |
| 109 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.45649243 |
| 110 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.44727372 |
| 111 | membrane depolarization during action potential (GO:0086010) | 2.43826295 |
| 112 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.43282134 |
| 113 | fibroblast migration (GO:0010761) | 2.41962328 |
| 114 | cAMP catabolic process (GO:0006198) | 2.40743608 |
| 115 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.40641061 |
| 116 | vesicle docking (GO:0048278) | 2.40488520 |
| 117 | glutamate secretion (GO:0014047) | 2.39994800 |
| 118 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.39296469 |
| 119 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.38733958 |
| 120 | signal peptide processing (GO:0006465) | 2.38628651 |
| 121 | synaptic vesicle exocytosis (GO:0016079) | 2.37944434 |
| 122 | lactate metabolic process (GO:0006089) | 2.37684913 |
| 123 | inner ear receptor cell development (GO:0060119) | 2.37401203 |
| 124 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.37154356 |
| 125 | sperm-egg recognition (GO:0035036) | 2.36988968 |
| 126 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.36824811 |
| 127 | regulation of protein glycosylation (GO:0060049) | 2.36022415 |
| 128 | positive regulation of meiosis (GO:0045836) | 2.34955490 |
| 129 | locomotory exploration behavior (GO:0035641) | 2.34743307 |
| 130 | prostate gland growth (GO:0060736) | 2.33361997 |
| 131 | innervation (GO:0060384) | 2.33071014 |
| 132 | vesicle docking involved in exocytosis (GO:0006904) | 2.32949755 |
| 133 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.32926497 |
| 134 | vascular smooth muscle contraction (GO:0014829) | 2.32528097 |
| 135 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.32454462 |
| 136 | positive regulation of growth hormone secretion (GO:0060124) | 2.32387584 |
| 137 | extracellular negative regulation of signal transduction (GO:1900116) | 2.30456788 |
| 138 | extracellular regulation of signal transduction (GO:1900115) | 2.30456788 |
| 139 | parental behavior (GO:0060746) | 2.29605624 |
| 140 | protein K11-linked deubiquitination (GO:0035871) | 2.28996500 |
| 141 | dentate gyrus development (GO:0021542) | 2.28512350 |
| 142 | neuron recognition (GO:0008038) | 2.27989554 |
| 143 | regulation of postsynaptic membrane potential (GO:0060078) | 2.27123591 |
| 144 | gamma-aminobutyric acid transport (GO:0015812) | 2.25031163 |
| 145 | regulation of cell communication by electrical coupling (GO:0010649) | 2.24923074 |
| 146 | type B pancreatic cell proliferation (GO:0044342) | 2.24820542 |
| 147 | synaptonemal complex organization (GO:0070193) | 2.24305466 |
| 148 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.24065160 |
| 149 | protein polyglutamylation (GO:0018095) | 2.23682653 |
| 150 | axonal fasciculation (GO:0007413) | 2.21362075 |
| 151 | serotonin receptor signaling pathway (GO:0007210) | 2.21097495 |
| 152 | regulation of pigment cell differentiation (GO:0050932) | 2.21022958 |
| 153 | vesicle transport along microtubule (GO:0047496) | 2.19969206 |
| 154 | regulation of sarcomere organization (GO:0060297) | 2.19094291 |
| 155 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.18266089 |
| 156 | C4-dicarboxylate transport (GO:0015740) | 2.17250007 |
| 157 | positive regulation of insulin secretion (GO:0032024) | 2.17145299 |
| 158 | renal tubule morphogenesis (GO:0061333) | 2.16642889 |
| 159 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.16136172 |
| 160 | sphingoid metabolic process (GO:0046519) | 2.14355247 |
| 161 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.13600218 |
| 162 | smooth muscle tissue development (GO:0048745) | 2.13275366 |
| 163 | coenzyme catabolic process (GO:0009109) | 2.10635271 |
| 164 | negative regulation of hormone metabolic process (GO:0032351) | 2.09658803 |
| 165 | regulation of dendritic spine development (GO:0060998) | 2.09637091 |
| 166 | cellular response to ethanol (GO:0071361) | 2.09337933 |
| 167 | pancreas development (GO:0031016) | 2.09239590 |
| 168 | smooth muscle contraction (GO:0006939) | 2.08878017 |
| 169 | response to redox state (GO:0051775) | 2.08794153 |
| 170 | phospholipid dephosphorylation (GO:0046839) | 2.08455669 |
| 171 | interkinetic nuclear migration (GO:0022027) | 2.08335107 |
| 172 | central nervous system neuron axonogenesis (GO:0021955) | 2.07997693 |
| 173 | positive regulation of peptide hormone secretion (GO:0090277) | 2.06797467 |
| 174 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.05442969 |
| 175 | peptide hormone secretion (GO:0030072) | 2.04738655 |
| 176 | nucleobase catabolic process (GO:0046113) | 2.03058953 |
| 177 | dendritic spine morphogenesis (GO:0060997) | 2.02741920 |
| 178 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.01298826 |
| 179 | peptide secretion (GO:0002790) | 2.01235540 |
| 180 | cellular response to leptin stimulus (GO:0044320) | 2.00320625 |
| 181 | negative regulation of acute inflammatory response (GO:0002674) | 2.00083385 |
| 182 | regulation of relaxation of muscle (GO:1901077) | 1.99984510 |
| 183 | positive regulation of phosphatase activity (GO:0010922) | 1.99383834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.62880902 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.00706964 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.35990584 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.76079578 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68388162 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.50248631 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.41567531 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.39409963 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17510405 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04125689 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.00062820 |
| 12 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.98409375 |
| 13 | P300_19829295_ChIP-Seq_ESCs_Human | 1.97149597 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.94595464 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.93995186 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.93782409 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.92493955 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89651411 |
| 19 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.88260752 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.85505916 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85262943 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.79757621 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79585774 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78342499 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76298095 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75407597 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72401816 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71555649 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70669514 |
| 30 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.68609342 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.65728929 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65598675 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65556293 |
| 34 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.65249223 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64824039 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.61504477 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.61341415 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.56948565 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.56948565 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56268220 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55916989 |
| 42 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.55157975 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54938833 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54827936 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.53576912 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53401746 |
| 47 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.52181520 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51975353 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51822678 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50374928 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49808198 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48805077 |
| 53 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.48519229 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48268732 |
| 55 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48268732 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46895678 |
| 57 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.46860521 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46252691 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44072748 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41933098 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40589037 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40442003 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.39765262 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39765262 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39533389 |
| 66 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.39415549 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39249683 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38740187 |
| 69 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.38735756 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38116306 |
| 71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38046113 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37798694 |
| 73 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37420689 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36932859 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36574773 |
| 76 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36140561 |
| 77 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.35856096 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35667409 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34989691 |
| 80 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.34362687 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.34138035 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33763121 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33741234 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33388004 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.32235569 |
| 86 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32142064 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32025310 |
| 88 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.31883150 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30088246 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29861229 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28523772 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.27584626 |
| 93 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26294829 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24272851 |
| 95 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23676573 |
| 96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23540563 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22917547 |
| 98 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.22555792 |
| 99 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.21997577 |
| 100 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21513259 |
| 101 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21375021 |
| 102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19651644 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19457127 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17734837 |
| 105 | KDM2B_26808549_Chip-Seq_REH_Human | 1.17653181 |
| 106 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17471068 |
| 107 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17215965 |
| 108 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16945664 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.15707632 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15369968 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14766204 |
| 112 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14342170 |
| 113 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.14017270 |
| 114 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.13585004 |
| 115 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13151750 |
| 116 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13151750 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12752963 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11250111 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10751390 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09280956 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07968082 |
| 122 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07491916 |
| 123 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06736832 |
| 124 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05417997 |
| 125 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04782317 |
| 126 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03530891 |
| 127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03253843 |
| 128 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02999853 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02510253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.56841101 |
| 2 | MP0005410_abnormal_fertilization | 3.52355829 |
| 3 | MP0003880_abnormal_central_pattern | 3.03265672 |
| 4 | MP0005646_abnormal_pituitary_gland | 3.00096857 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.89718393 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.80201299 |
| 7 | MP0003195_calcinosis | 2.53201805 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.43246657 |
| 9 | MP0003787_abnormal_imprinting | 2.34741754 |
| 10 | MP0003122_maternal_imprinting | 2.29196783 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.28354513 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.25162220 |
| 13 | MP0009745_abnormal_behavioral_response | 2.24815704 |
| 14 | MP0009046_muscle_twitch | 2.17220010 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.16951290 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.15988893 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.12772736 |
| 18 | MP0010386_abnormal_urinary_bladder | 2.07974979 |
| 19 | MP0006054_spinal_hemorrhage | 2.02876820 |
| 20 | MP0002064_seizures | 1.99778023 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.96393938 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.88425318 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.87200465 |
| 24 | MP0004270_analgesia | 1.86620193 |
| 25 | MP0005171_absent_coat_pigmentation | 1.86350306 |
| 26 | MP0001188_hyperpigmentation | 1.85972472 |
| 27 | MP0001486_abnormal_startle_reflex | 1.84756536 |
| 28 | MP0002736_abnormal_nociception_after | 1.83863790 |
| 29 | MP0004742_abnormal_vestibular_system | 1.83787070 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.82676858 |
| 31 | MP0000749_muscle_degeneration | 1.82091512 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.80330547 |
| 33 | MP0003698_abnormal_male_reproductive | 1.79395495 |
| 34 | MP0001984_abnormal_olfaction | 1.77172534 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.74314885 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.72300190 |
| 37 | MP0009697_abnormal_copulation | 1.72265969 |
| 38 | MP0004134_abnormal_chest_morphology | 1.69303519 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.67609842 |
| 40 | MP0002272_abnormal_nervous_system | 1.66543461 |
| 41 | MP0005275_abnormal_skin_tensile | 1.64891809 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.64112532 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.61649474 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.61206934 |
| 45 | MP0000778_abnormal_nervous_system | 1.60019998 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.55475321 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.55178144 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.54000155 |
| 49 | MP0002102_abnormal_ear_morphology | 1.53197038 |
| 50 | MP0002928_abnormal_bile_duct | 1.52189469 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.46648744 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.44812236 |
| 53 | MP0004885_abnormal_endolymph | 1.39729128 |
| 54 | MP0003121_genomic_imprinting | 1.37083913 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.34485976 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.33732575 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.30981712 |
| 58 | MP0004510_myositis | 1.30931206 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.30664574 |
| 60 | MP0004924_abnormal_behavior | 1.30664574 |
| 61 | MP0000751_myopathy | 1.28809593 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.27832746 |
| 63 | MP0002184_abnormal_innervation | 1.25724039 |
| 64 | MP0008569_lethality_at_weaning | 1.24779334 |
| 65 | MP0008004_abnormal_stomach_pH | 1.23067350 |
| 66 | MP0003283_abnormal_digestive_organ | 1.22374526 |
| 67 | MP0001299_abnormal_eye_distance/ | 1.21712534 |
| 68 | MP0003879_abnormal_hair_cell | 1.21526171 |
| 69 | MP0001958_emphysema | 1.21077540 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.19912948 |
| 71 | MP0001929_abnormal_gametogenesis | 1.17552892 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.16595709 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 1.16031559 |
| 74 | MP0000516_abnormal_urinary_system | 1.16031559 |
| 75 | MP0004036_abnormal_muscle_relaxation | 1.13955697 |
| 76 | MP0004811_abnormal_neuron_physiology | 1.08685475 |
| 77 | MP0002168_other_aberrant_phenotype | 1.08524584 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 1.08357845 |
| 79 | MP0001661_extended_life_span | 1.07703285 |
| 80 | MP0003252_abnormal_bile_duct | 1.06599101 |
| 81 | MP0001529_abnormal_vocalization | 1.05176662 |
| 82 | MP0004084_abnormal_cardiac_muscle | 1.05122652 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.05032108 |
| 84 | MP0005248_abnormal_Harderian_gland | 1.05029200 |
| 85 | MP0004043_abnormal_pH_regulation | 1.04481191 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 1.03670545 |
| 87 | MP0002693_abnormal_pancreas_physiology | 1.03299658 |
| 88 | MP0006072_abnormal_retinal_apoptosis | 1.02040600 |
| 89 | MP0002332_abnormal_exercise_endurance | 1.01499585 |
| 90 | MP0003279_aneurysm | 1.01413265 |
| 91 | MP0003868_abnormal_feces_composition | 1.01075129 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 1.00035318 |
| 93 | MP0000566_synostosis | 0.99264404 |
| 94 | MP0002127_abnormal_cardiovascular_syste | 0.98363451 |
| 95 | MP0005253_abnormal_eye_physiology | 0.97292317 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.96119377 |
| 97 | MP0004142_abnormal_muscle_tone | 0.95993350 |
| 98 | MP0005423_abnormal_somatic_nervous | 0.95309664 |
| 99 | MP0002269_muscular_atrophy | 0.92954837 |
| 100 | MP0003045_fibrosis | 0.92077300 |
| 101 | MP0010329_abnormal_lipoprotein_level | 0.91975834 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.91854061 |
| 103 | MP0006292_abnormal_olfactory_placode | 0.91633016 |
| 104 | MP0003633_abnormal_nervous_system | 0.90925636 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.90620441 |
| 106 | MP0004085_abnormal_heartbeat | 0.90359262 |
| 107 | MP0002882_abnormal_neuron_morphology | 0.89554742 |
| 108 | MP0005409_darkened_coat_color | 0.89409689 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.89208775 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.89067988 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.88874975 |
| 112 | MP0001970_abnormal_pain_threshold | 0.88841021 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.87929907 |
| 114 | MP0000383_abnormal_hair_follicle | 0.87766072 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.87344630 |
| 116 | MP0002009_preneoplasia | 0.87002352 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.86527785 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.84355784 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.83698501 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.83164023 |
| 121 | MP0002210_abnormal_sex_determination | 0.82880358 |
| 122 | MP0002163_abnormal_gland_morphology | 0.82684136 |
| 123 | MP0005187_abnormal_penis_morphology | 0.82456538 |
| 124 | MP0004484_altered_response_of | 0.82316702 |
| 125 | MP0001756_abnormal_urination | 0.81173490 |
| 126 | MP0000955_abnormal_spinal_cord | 0.80808527 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.80524407 |
| 128 | MP0002108_abnormal_muscle_morphology | 0.79254392 |
| 129 | MP0005369_muscle_phenotype | 0.77316865 |
| 130 | MP0001542_abnormal_bone_strength | 0.77225127 |
| 131 | MP0002161_abnormal_fertility/fecundity | 0.76022520 |
| 132 | MP0003385_abnormal_body_wall | 0.75343536 |
| 133 | MP0001177_atelectasis | 0.75142326 |
| 134 | MP0002166_altered_tumor_susceptibility | 0.74558664 |
| 135 | MP0003631_nervous_system_phenotype | 0.74156728 |
| 136 | MP0010368_abnormal_lymphatic_system | 0.74103852 |
| 137 | MP0003950_abnormal_plasma_membrane | 0.72872607 |
| 138 | MP0000427_abnormal_hair_cycle | 0.72776484 |
| 139 | MP0001905_abnormal_dopamine_level | 0.71606739 |
| 140 | MP0001986_abnormal_taste_sensitivity | 0.71006715 |
| 141 | MP0002733_abnormal_thermal_nociception | 0.70295059 |
| 142 | MP0002896_abnormal_bone_mineralization | 0.70184951 |
| 143 | MP0002152_abnormal_brain_morphology | 0.69978751 |
| 144 | MP0005379_endocrine/exocrine_gland_phen | 0.68701741 |
| 145 | MP0005257_abnormal_intraocular_pressure | 0.67085108 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.65991851 |
| 147 | MP0004233_abnormal_muscle_weight | 0.65096099 |
| 148 | MP0005620_abnormal_muscle_contractility | 0.64470520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent/shortened dynein arms (HP:0200106) | 6.17006660 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.17006660 |
| 3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.77911930 |
| 4 | Focal motor seizures (HP:0011153) | 4.68591405 |
| 5 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.77734004 |
| 6 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.52684294 |
| 7 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.52684294 |
| 8 | Hyperventilation (HP:0002883) | 3.44633524 |
| 9 | Abnormal ciliary motility (HP:0012262) | 3.43780285 |
| 10 | Nephronophthisis (HP:0000090) | 3.38159164 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.36970253 |
| 12 | Hypothermia (HP:0002045) | 3.27343575 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 3.27271418 |
| 14 | Hemiparesis (HP:0001269) | 3.18209392 |
| 15 | Rhinitis (HP:0012384) | 3.13554538 |
| 16 | Absent eyebrow (HP:0002223) | 3.10825214 |
| 17 | Protruding tongue (HP:0010808) | 3.03952835 |
| 18 | Congenital sensorineural hearing impairment (HP:0008527) | 3.03739245 |
| 19 | Hyperglycemia (HP:0003074) | 2.97638786 |
| 20 | Hypoglycemic coma (HP:0001325) | 2.96978115 |
| 21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.96574930 |
| 22 | Ketoacidosis (HP:0001993) | 2.91795337 |
| 23 | Chronic hepatic failure (HP:0100626) | 2.90342121 |
| 24 | Febrile seizures (HP:0002373) | 2.88981655 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 2.86221732 |
| 26 | Bell-shaped thorax (HP:0001591) | 2.85052219 |
| 27 | Tubulointerstitial nephritis (HP:0001970) | 2.84855875 |
| 28 | Metaphyseal dysplasia (HP:0100255) | 2.78926834 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.75717963 |
| 30 | Abnormality of the renal medulla (HP:0100957) | 2.72892146 |
| 31 | Thyroid carcinoma (HP:0002890) | 2.70788113 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.62725763 |
| 33 | Abnormality of midbrain morphology (HP:0002418) | 2.62725763 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 2.60382568 |
| 35 | Hamartoma of the eye (HP:0010568) | 2.58205124 |
| 36 | Blue irides (HP:0000635) | 2.54420152 |
| 37 | Atonic seizures (HP:0010819) | 2.52330498 |
| 38 | Retinal dysplasia (HP:0007973) | 2.49751098 |
| 39 | Fetal akinesia sequence (HP:0001989) | 2.47764443 |
| 40 | Intention tremor (HP:0002080) | 2.45535601 |
| 41 | Large for gestational age (HP:0001520) | 2.45250974 |
| 42 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.44987342 |
| 43 | Progressive cerebellar ataxia (HP:0002073) | 2.42431363 |
| 44 | Focal seizures (HP:0007359) | 2.41205253 |
| 45 | Neoplasm of the heart (HP:0100544) | 2.40203458 |
| 46 | Thyroiditis (HP:0100646) | 2.37044606 |
| 47 | Hematochezia (HP:0002573) | 2.36786708 |
| 48 | Unilateral renal agenesis (HP:0000122) | 2.34230756 |
| 49 | Absent speech (HP:0001344) | 2.32814673 |
| 50 | Abnormal hair whorl (HP:0010721) | 2.32451838 |
| 51 | Muscle fiber inclusion bodies (HP:0100299) | 2.32194183 |
| 52 | Nemaline bodies (HP:0003798) | 2.30735525 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.30422440 |
| 54 | Fibular hypoplasia (HP:0003038) | 2.24867998 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 2.23842963 |
| 56 | Striae distensae (HP:0001065) | 2.22356348 |
| 57 | Excessive salivation (HP:0003781) | 2.22064305 |
| 58 | Drooling (HP:0002307) | 2.22064305 |
| 59 | Fair hair (HP:0002286) | 2.21960497 |
| 60 | Widely spaced teeth (HP:0000687) | 2.21852223 |
| 61 | Genital tract atresia (HP:0001827) | 2.21840306 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.19768254 |
| 63 | Abnormality of vitamin B metabolism (HP:0004340) | 2.18260559 |
| 64 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.17939202 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.16843244 |
| 66 | Menstrual irregularities (HP:0000858) | 2.14509946 |
| 67 | Pheochromocytoma (HP:0002666) | 2.13660965 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.13566448 |
| 69 | Follicular hyperkeratosis (HP:0007502) | 2.12917729 |
| 70 | Absence seizures (HP:0002121) | 2.12725046 |
| 71 | Pancreatic fibrosis (HP:0100732) | 2.12318227 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.11608582 |
| 73 | Mitral stenosis (HP:0001718) | 2.09754915 |
| 74 | Decreased central vision (HP:0007663) | 2.09261322 |
| 75 | Generalized hypopigmentation of hair (HP:0011358) | 2.08278926 |
| 76 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07846120 |
| 77 | Subaortic stenosis (HP:0001682) | 2.07846120 |
| 78 | Abnormality of incisor morphology (HP:0011063) | 2.07049681 |
| 79 | True hermaphroditism (HP:0010459) | 2.06419458 |
| 80 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.06328081 |
| 81 | Renal dysplasia (HP:0000110) | 2.04928009 |
| 82 | Methylmalonic acidemia (HP:0002912) | 2.03554927 |
| 83 | Epileptiform EEG discharges (HP:0011182) | 2.02142211 |
| 84 | Distal arthrogryposis (HP:0005684) | 2.01653186 |
| 85 | Abnormality of the renal cortex (HP:0011035) | 2.01288133 |
| 86 | Symptomatic seizures (HP:0011145) | 1.98524865 |
| 87 | Hyperphosphatemia (HP:0002905) | 1.97174846 |
| 88 | Type II lissencephaly (HP:0007260) | 1.97036924 |
| 89 | Bundle branch block (HP:0011710) | 1.96998576 |
| 90 | Papillary thyroid carcinoma (HP:0002895) | 1.96673624 |
| 91 | Frequent falls (HP:0002359) | 1.94407478 |
| 92 | Delayed gross motor development (HP:0002194) | 1.92968749 |
| 93 | Downturned corners of mouth (HP:0002714) | 1.92118905 |
| 94 | Volvulus (HP:0002580) | 1.91759073 |
| 95 | Dialeptic seizures (HP:0011146) | 1.91238912 |
| 96 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90878867 |
| 97 | Vaginal atresia (HP:0000148) | 1.90712672 |
| 98 | Congenital primary aphakia (HP:0007707) | 1.87934087 |
| 99 | Gait imbalance (HP:0002141) | 1.87662280 |
| 100 | Ketosis (HP:0001946) | 1.86552671 |
| 101 | Short tibia (HP:0005736) | 1.86312956 |
| 102 | White forelock (HP:0002211) | 1.85496394 |
| 103 | Proximal amyotrophy (HP:0007126) | 1.85245186 |
| 104 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.85007009 |
| 105 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.85007009 |
| 106 | Postaxial foot polydactyly (HP:0001830) | 1.84157420 |
| 107 | Broad-based gait (HP:0002136) | 1.82576850 |
| 108 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.81681245 |
| 109 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.81681245 |
| 110 | Astrocytoma (HP:0009592) | 1.81615567 |
| 111 | Abnormality of the astrocytes (HP:0100707) | 1.81615567 |
| 112 | Late onset (HP:0003584) | 1.81529100 |
| 113 | Abnormal pancreas size (HP:0012094) | 1.81241319 |
| 114 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.80681442 |
| 115 | Hypoplasia of the fovea (HP:0007750) | 1.80681442 |
| 116 | Postaxial hand polydactyly (HP:0001162) | 1.79560597 |
| 117 | EEG with generalized epileptiform discharges (HP:0011198) | 1.77841957 |
| 118 | Nephropathy (HP:0000112) | 1.77809200 |
| 119 | Poor coordination (HP:0002370) | 1.77449626 |
| 120 | Enlarged penis (HP:0000040) | 1.77320879 |
| 121 | Neuroendocrine neoplasm (HP:0100634) | 1.76939549 |
| 122 | Truncal ataxia (HP:0002078) | 1.76224162 |
| 123 | Increased CSF protein (HP:0002922) | 1.75804845 |
| 124 | Hyperkalemia (HP:0002153) | 1.75061098 |
| 125 | Long clavicles (HP:0000890) | 1.74998577 |
| 126 | Tubular atrophy (HP:0000092) | 1.74485677 |
| 127 | Glucose intolerance (HP:0000833) | 1.74107035 |
| 128 | Infertility (HP:0000789) | 1.73992021 |
| 129 | Tubulointerstitial abnormality (HP:0001969) | 1.73617069 |
| 130 | Generalized tonic-clonic seizures (HP:0002069) | 1.73163317 |
| 131 | Left ventricular hypertrophy (HP:0001712) | 1.72534970 |
| 132 | Exocrine pancreatic insufficiency (HP:0001738) | 1.72287264 |
| 133 | Neoplasm of the adrenal cortex (HP:0100641) | 1.71814336 |
| 134 | EMG: myopathic abnormalities (HP:0003458) | 1.71081729 |
| 135 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.70534661 |
| 136 | Intestinal atresia (HP:0011100) | 1.70318110 |
| 137 | Renal cortical cysts (HP:0000803) | 1.70168378 |
| 138 | Absent frontal sinuses (HP:0002688) | 1.69343674 |
| 139 | Microglossia (HP:0000171) | 1.69312105 |
| 140 | Intellectual disability, moderate (HP:0002342) | 1.69255835 |
| 141 | Round ear (HP:0100830) | 1.69153362 |
| 142 | Patchy hypopigmentation of hair (HP:0011365) | 1.68507543 |
| 143 | Abnormality of the right ventricle (HP:0001707) | 1.68072882 |
| 144 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.66437385 |
| 145 | Abnormality of vitamin metabolism (HP:0100508) | 1.65929908 |
| 146 | Abnormality of dental color (HP:0011073) | 1.65806866 |
| 147 | Abnormality of the fovea (HP:0000493) | 1.65615443 |
| 148 | Open mouth (HP:0000194) | 1.64368058 |
| 149 | Chronic bronchitis (HP:0004469) | 1.63977253 |
| 150 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.63384423 |
| 151 | Congenital hepatic fibrosis (HP:0002612) | 1.61981109 |
| 152 | Bradycardia (HP:0001662) | 1.61500261 |
| 153 | Irregular vertebral endplates (HP:0003301) | 1.60351936 |
| 154 | Atrial fibrillation (HP:0005110) | 1.60348142 |
| 155 | Cystic liver disease (HP:0006706) | 1.59592116 |
| 156 | Truncal obesity (HP:0001956) | 1.59554718 |
| 157 | Lissencephaly (HP:0001339) | 1.58892910 |
| 158 | Abnormality of the vertebral endplates (HP:0005106) | 1.58818786 |
| 159 | Flattened epiphyses (HP:0003071) | 1.58195279 |
| 160 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.58180808 |
| 161 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.57517573 |
| 162 | Hip dysplasia (HP:0001385) | 1.56717226 |
| 163 | Hypsarrhythmia (HP:0002521) | 1.55912411 |
| 164 | Hypoplastic ischia (HP:0003175) | 1.54891439 |
| 165 | Dyschromatopsia (HP:0007641) | 1.54796516 |
| 166 | Inability to walk (HP:0002540) | 1.54706195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.94729775 |
| 2 | SIK3 | 3.59160543 |
| 3 | NTRK3 | 3.51218079 |
| 4 | EPHA4 | 2.82225500 |
| 5 | MAP2K7 | 2.65406087 |
| 6 | INSRR | 2.59951091 |
| 7 | PRPF4B | 2.59742022 |
| 8 | MAP3K4 | 2.39609652 |
| 9 | PDK4 | 2.29582316 |
| 10 | PDK3 | 2.29582316 |
| 11 | SGK2 | 2.23418977 |
| 12 | PLK2 | 2.23133217 |
| 13 | PHKG1 | 1.92476132 |
| 14 | PHKG2 | 1.92476132 |
| 15 | PTK2B | 1.88235050 |
| 16 | CDK8 | 1.76096280 |
| 17 | TRIM28 | 1.72832514 |
| 18 | MAP4K2 | 1.72097285 |
| 19 | RIPK4 | 1.70307787 |
| 20 | PRKD3 | 1.67259033 |
| 21 | NEK9 | 1.66090318 |
| 22 | SGK494 | 1.64566952 |
| 23 | SGK223 | 1.64566952 |
| 24 | TNIK | 1.60323404 |
| 25 | SGK3 | 1.58542583 |
| 26 | PDK2 | 1.52207822 |
| 27 | AKT3 | 1.49465618 |
| 28 | NUAK1 | 1.46213785 |
| 29 | TAOK3 | 1.44787330 |
| 30 | BMPR2 | 1.41242134 |
| 31 | EPHA3 | 1.41013368 |
| 32 | CAMK1G | 1.39264110 |
| 33 | WNK3 | 1.36531303 |
| 34 | MAPK13 | 1.34836053 |
| 35 | DAPK2 | 1.33316704 |
| 36 | CCNB1 | 1.31641625 |
| 37 | SIK1 | 1.29948327 |
| 38 | SIK2 | 1.29829845 |
| 39 | MAP2K4 | 1.28168931 |
| 40 | LATS1 | 1.25965183 |
| 41 | EIF2AK3 | 1.23343353 |
| 42 | BMPR1B | 1.21843118 |
| 43 | FRK | 1.17666310 |
| 44 | PNCK | 1.16913214 |
| 45 | NTRK2 | 1.16385776 |
| 46 | TXK | 1.15426334 |
| 47 | CSNK1G1 | 1.14426180 |
| 48 | YES1 | 1.11300064 |
| 49 | MYLK | 1.08228105 |
| 50 | MAP3K12 | 1.07693516 |
| 51 | ERBB3 | 1.07030016 |
| 52 | PIK3CA | 1.02515927 |
| 53 | ZAK | 1.01102754 |
| 54 | FGFR3 | 1.00405094 |
| 55 | STK38L | 0.99507921 |
| 56 | MINK1 | 0.99214986 |
| 57 | CAMKK2 | 0.97048929 |
| 58 | WNK4 | 0.96405420 |
| 59 | PIK3CG | 0.96013252 |
| 60 | WNK1 | 0.95987115 |
| 61 | STK3 | 0.92246756 |
| 62 | CDK3 | 0.91052506 |
| 63 | JAK1 | 0.88625423 |
| 64 | MST4 | 0.85565808 |
| 65 | ACVR1B | 0.84068610 |
| 66 | CAMK2A | 0.83275562 |
| 67 | PRKCE | 0.81945733 |
| 68 | MARK3 | 0.81111544 |
| 69 | OXSR1 | 0.81098887 |
| 70 | SGK1 | 0.80873822 |
| 71 | CSNK1G3 | 0.77710080 |
| 72 | NLK | 0.76338555 |
| 73 | CAMK1D | 0.75285665 |
| 74 | DMPK | 0.72599714 |
| 75 | KSR1 | 0.72173014 |
| 76 | STK24 | 0.71217769 |
| 77 | PRKCQ | 0.69914961 |
| 78 | MAP3K13 | 0.68864917 |
| 79 | BCR | 0.67711519 |
| 80 | STK38 | 0.67670389 |
| 81 | ADRBK2 | 0.67606712 |
| 82 | GRK1 | 0.66396626 |
| 83 | PRKCG | 0.65278586 |
| 84 | CAMK1 | 0.65232996 |
| 85 | PRKAA2 | 0.65111662 |
| 86 | CAMK4 | 0.64921955 |
| 87 | CSNK1A1L | 0.64460095 |
| 88 | RPS6KB1 | 0.64262126 |
| 89 | ROCK1 | 0.64258143 |
| 90 | DAPK1 | 0.63824369 |
| 91 | BRSK2 | 0.63606450 |
| 92 | CAMKK1 | 0.63600820 |
| 93 | CDK5 | 0.63442792 |
| 94 | PASK | 0.62404418 |
| 95 | OBSCN | 0.61558359 |
| 96 | MARK1 | 0.61396525 |
| 97 | CAMK2D | 0.56782428 |
| 98 | PRKCH | 0.55051233 |
| 99 | MUSK | 0.55001145 |
| 100 | BRAF | 0.54697219 |
| 101 | NEK6 | 0.54043471 |
| 102 | PAK3 | 0.53543546 |
| 103 | DYRK1A | 0.53022940 |
| 104 | MAP2K1 | 0.52977545 |
| 105 | MKNK2 | 0.52927818 |
| 106 | GRK7 | 0.52873897 |
| 107 | MAP3K2 | 0.52720604 |
| 108 | MARK2 | 0.51925807 |
| 109 | MAP3K14 | 0.51853758 |
| 110 | HIPK2 | 0.51634077 |
| 111 | FER | 0.50738929 |
| 112 | STK39 | 0.50643209 |
| 113 | STK11 | 0.50339461 |
| 114 | PRKG1 | 0.50157250 |
| 115 | CSNK1D | 0.48709713 |
| 116 | PDK1 | 0.45097042 |
| 117 | TEC | 0.44355363 |
| 118 | CDC42BPA | 0.43161971 |
| 119 | TESK1 | 0.42729225 |
| 120 | PDGFRB | 0.41605532 |
| 121 | DDR2 | 0.40910613 |
| 122 | PINK1 | 0.40625758 |
| 123 | TIE1 | 0.40464341 |
| 124 | TRPM7 | 0.39951854 |
| 125 | GSK3A | 0.39407444 |
| 126 | CAMK2B | 0.39276890 |
| 127 | PRKACB | 0.39103220 |
| 128 | TGFBR2 | 0.39095235 |
| 129 | PDGFRA | 0.38222376 |
| 130 | LIMK1 | 0.37924630 |
| 131 | RPS6KA2 | 0.37548685 |
| 132 | PRKD1 | 0.37231586 |
| 133 | PRKAA1 | 0.37081530 |
| 134 | PRKACA | 0.37075064 |
| 135 | ABL1 | 0.36822220 |
| 136 | IRAK1 | 0.36753047 |
| 137 | FGFR2 | 0.36747612 |
| 138 | NME1 | 0.35835579 |
| 139 | CSNK1G2 | 0.35387976 |
| 140 | BRD4 | 0.34405447 |
| 141 | RET | 0.33872942 |
| 142 | MAPK7 | 0.33614184 |
| 143 | ADRBK1 | 0.29608027 |
| 144 | PDPK1 | 0.29309332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.18019602 |
| 2 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46644780 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36780150 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.35786919 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.31759256 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21734520 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19365877 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.13268412 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06379451 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.01946781 |
| 11 | Renin secretion_Homo sapiens_hsa04924 | 1.93645782 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.81671458 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.78645704 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78246552 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73049849 |
| 16 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71477338 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.69124241 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62971556 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.62313648 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.61607455 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46154495 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45997545 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.45500437 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45464312 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42841206 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.42223234 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.41647664 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.41418419 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40116633 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.39353301 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.38704708 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.36629555 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35568365 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.35202132 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31704225 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.27527314 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26512827 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26198363 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.20692270 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.19929327 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18833937 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.17557228 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.16286542 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11009932 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06761862 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06055461 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05696524 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02513770 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00796700 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99968481 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96961498 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96468385 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95849351 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93363447 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.93272918 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91750361 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90933523 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.89731666 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88448209 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84787619 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84770440 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82232554 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81732536 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.81650092 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81398559 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79609762 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.79267353 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78575940 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78053332 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77818337 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77357042 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75556357 |
| 73 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.74572983 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73704443 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72300059 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71031123 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69993327 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68209350 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68117178 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68061625 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67372845 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.66921438 |
| 83 | Melanoma_Homo sapiens_hsa05218 | 0.65957229 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65430207 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64819454 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63815001 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.63547419 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.61579667 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61491878 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61341096 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.60639366 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60498382 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59955606 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59236640 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58914800 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57264478 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57172365 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56715982 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55890545 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53812162 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.52759380 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51253136 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50487556 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48741359 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48596026 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47188083 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47169049 |
| 108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46618333 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45428922 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45130603 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44581473 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44203088 |
| 113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42917124 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42417131 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40484992 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40144469 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39797494 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39789154 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.39592761 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38696686 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37733079 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37725068 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.37699618 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36940732 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36849610 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34962386 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33257664 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33100249 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32938166 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.31970401 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31236636 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30684121 |

